mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |